3rd Global Adolescent & Young Adult Cancer Congress
 

Speakers

Keynote and invited speakers are currently being confirmed and will be continuously updated over the coming months. Sign up for regular updates via the CONTACT page.

A/Professor Prue Cormie [More details]
Affiliations: Principal Research Fellow – Exercise Oncology, Australian Catholic University; Chair COSA Exercise Cancer Group
Topic: The evidence for exercise as a component of cancer care and the 2018 Clinical Oncology Society of Australia Position Statement on Exercise in Cancer Care
 
Professor Kevin C. Oeffinger [More details]
Affiliations: Professor of Medicine, Professor in the Department of Community and Family Medicine, Duke University School of Medicine; Member of the Duke Cancer Institute
Topic: AYA cancer survivorship care including the role of telemedicine and community-based survivorship approaches linking cancer care centres with primary care
 
Ms Lynne Pezzullo [More details]
Affiliations: Lead Partner, Health Economics and Social Policy at Deloitte Access Economics, Managing Partner, Deloitte Canberra
Topic: Financial toxicity during and after AYA cancer and the findings of the Deloitte Access Economics Cost of AYA Cancer Report
 
Professor H. Miles Prince [More details]
Affiliations: Professor/Director of Molecular Oncology and Cancer Immunology at Epworth Healthcare; Professor, Monash University and University of Melbourne; Director, Centre for Blood Cell Therapy, Peter MacCallum Cancer Centre
Topic: Immunotherapies in the treatment of AYA cancers including promising directions in the treatment of solid tumours
 
Professor Richard Scolyer [More details]
Affiliations: Co-Medical Director and Consultant Pathologist at Melanoma Institute Australia; Senior Staff Specialist, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney; and Clinical Professor, The University of Sydney
Topic: Melanoma in adolescents and young adults, including challenges in diagnosis, Australian and international approaches to risk reduction and advances in treatment.
 
Professor David Thomas [More details]
Affiliations: Director, The Kinghorn Cancer Centre; Division Head, Cancer; Lab Head, Genomic Cancer Medicine, The Garvan Institute of Medical Research
Topic: The role of precision medicine in treating AYA cancers and AYA clinical trials access
 
Ms Heidi Watson [More details]
Affiliations: National Clinical Lead, AYA Cancer Network Aotearoa; Clinical Lecturer in Youth Health, Department of Paediatrics, The University of Auckland
Topic: Cancer in Maori and Pacific adolescents and young adults
 
Dr Allison Werner-Lin [More details]
Affiliations: Assistant Professor, University of Pennsylvania; Adjunct Investigator, National Cancer Institute, Division of Cancer Epidemiology And Genetics; Director, Social Work in Health Care Specialization; Chair, Advanced Clinical Social Work Practice
Topic: Inherited cancer risk and ethical and communication challenges related to disclosure and patient care